RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재후보

      쇼그렌 증후군 환자에서 발생한 Mycobacterium Massiliense에 의한 재발성 폐렴 = A Case of Mycobacterium Massiliense Infection Presenting as Recurrent Pneumonia in Sjogren`s Syndrome

      한글로보기

      https://www.riss.kr/link?id=A60204343

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Mycobacterium massiliense is an emerging pathogen that is increasingly reported as a causative agent occurring during medical procedures, at surgical sites, and intramuscularly [1]. Although previously classified as part of M. abscessus, M. massiliense has recently been identified as a new species of rapidly growing nontuberculous mycobacteria [1,3] via a comparative sequence analysis of rpoB and hsp65 [3,5]. However, the clinical manifestations of M. massiliense have not been well characterized. We report here in a case of recurrent pneumonia for 3 years that improved with antibiotic treatment for M. massiliense in a 37-year-old woman with Sjogren`s syndrome. The patient showed a substantial response to treatment with a combination of antimicrobial therapies comprising clarithromycin and amikacin without cefoxitin for 6 months. This is the first report of pulmonary infection of M. massiliense with Sjogren`s syndrome in Korea.
      번역하기

      Mycobacterium massiliense is an emerging pathogen that is increasingly reported as a causative agent occurring during medical procedures, at surgical sites, and intramuscularly [1]. Although previously classified as part of M. abscessus, M. massiliens...

      Mycobacterium massiliense is an emerging pathogen that is increasingly reported as a causative agent occurring during medical procedures, at surgical sites, and intramuscularly [1]. Although previously classified as part of M. abscessus, M. massiliense has recently been identified as a new species of rapidly growing nontuberculous mycobacteria [1,3] via a comparative sequence analysis of rpoB and hsp65 [3,5]. However, the clinical manifestations of M. massiliense have not been well characterized. We report here in a case of recurrent pneumonia for 3 years that improved with antibiotic treatment for M. massiliense in a 37-year-old woman with Sjogren`s syndrome. The patient showed a substantial response to treatment with a combination of antimicrobial therapies comprising clarithromycin and amikacin without cefoxitin for 6 months. This is the first report of pulmonary infection of M. massiliense with Sjogren`s syndrome in Korea.

      더보기

      참고문헌 (Reference)

      1 김정만, "비결핵항산균 감염증 환자에서 분리된 신속발육항산균의약제 감수성과 임상적 의의" 대한임상미생물학회 10 (10): 143-149, 2007

      2 Kim HY, "Proportions of Mycobacterium massiliense and Mycobacterium bolletii strains among Korean Mycobacterium chelonae-Mycobacterium abscessus group isolates" 46 : 3384-3390, 2008

      3 주세익, "Outbreak of Mycobacterium massiliense infection associated with intramuscular injections" AMER SOC MICROBIOLOGY 45 : 3127-3130, 200709

      4 Management of opportunist mycobacterial infections, "Joint Tuberculosis Committee Guidelines 1999: Subcommittee of the Joint Tuberculosis Committee of the British Thoracic Society" 55 : 210-218, 2000

      5 Simmon KE, "Identification of an emerging pathogen, Mycobacterium massiliense, by rpoB sequencing of clinical isolates collected in the United States" 45 : 1978-1980, 2007

      6 Won-Jung Koh, "Diagnosis and Treatment of Nontuberculous Mycobacterial Pulmonary Diseases: A Korean Perspective" 대한의학회 20 (20): 913-925, 2005

      7 Koh WJ, "Clinical significance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus" 183 : 405-410, 2011

      8 Bastian S, "Assessment of clarithromycin susceptibility in strains belonging to the Mycobacterium abscessus group by erm (41) and rrl sequencing" 55 : 775-781, 2011

      9 Griffith DE, "An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases" 175 : 367-416, 2007

      10 Jung-Wan Yoo, "A Case of Mycobacterium massiliense Infection Presenting as Pneumonia Resistant to Antibiotics in an Immunocompetent Host" 대한결핵및호흡기학회 69 (69): 39-42, 2010

      1 김정만, "비결핵항산균 감염증 환자에서 분리된 신속발육항산균의약제 감수성과 임상적 의의" 대한임상미생물학회 10 (10): 143-149, 2007

      2 Kim HY, "Proportions of Mycobacterium massiliense and Mycobacterium bolletii strains among Korean Mycobacterium chelonae-Mycobacterium abscessus group isolates" 46 : 3384-3390, 2008

      3 주세익, "Outbreak of Mycobacterium massiliense infection associated with intramuscular injections" AMER SOC MICROBIOLOGY 45 : 3127-3130, 200709

      4 Management of opportunist mycobacterial infections, "Joint Tuberculosis Committee Guidelines 1999: Subcommittee of the Joint Tuberculosis Committee of the British Thoracic Society" 55 : 210-218, 2000

      5 Simmon KE, "Identification of an emerging pathogen, Mycobacterium massiliense, by rpoB sequencing of clinical isolates collected in the United States" 45 : 1978-1980, 2007

      6 Won-Jung Koh, "Diagnosis and Treatment of Nontuberculous Mycobacterial Pulmonary Diseases: A Korean Perspective" 대한의학회 20 (20): 913-925, 2005

      7 Koh WJ, "Clinical significance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus" 183 : 405-410, 2011

      8 Bastian S, "Assessment of clarithromycin susceptibility in strains belonging to the Mycobacterium abscessus group by erm (41) and rrl sequencing" 55 : 775-781, 2011

      9 Griffith DE, "An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases" 175 : 367-416, 2007

      10 Jung-Wan Yoo, "A Case of Mycobacterium massiliense Infection Presenting as Pneumonia Resistant to Antibiotics in an Immunocompetent Host" 대한결핵및호흡기학회 69 (69): 39-42, 2010

      더보기

      동일학술지(권/호) 다른 논문

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 계속평가 신청대상 (계속평가)
      2021-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      2018-12-01 평가 등재후보 탈락 (계속평가)
      2017-12-01 평가 등재후보로 하락 (계속평가) KCI등재후보
      2013-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2010-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2008-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2006-05-15 학술지명변경 외국어명 : Korean Journal of Medicine -> The Korean Journal of Medicine KCI등재
      2006-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2003-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2002-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2000-07-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.1 0.1 0.1
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.11 0.1 0.259 0.02
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼